Health

What was big at AACR? A drug, a diagnostic, and a dog. Oh and a vaccine, too.

Angus Chen, a seasoned journalist covering all issues related to cancer, including drugs, policy, science, and equity, joined STAT in 2021 after a successful stint at NPR and NPR affiliate stations. His impressive body of work has been recognized with prestigious awards such as national Edward R. Murrow awards and the June L. Biedler prize for cancer journalism. You can connect with Angus on Signal at angus.08.

Welcome to the web edition of AACR in 30 Seconds, STAT’s comprehensive guide to the American Association for Cancer Research annual meeting.

Allow us to introduce you to Jae, a mysterious figure who exudes an air of intrigue. When questioned about her area of expertise, Jae responded with a cheerful smile akin to that of a happy puppy before disappearing into the bustling exhibition hall. Based on her enigmatic presence alone, we hereby bestow upon her the honorary title of the mayor of AACR.

Don’t forget to tune in to our virtual event tomorrow, where we will delve into pivotal data and address any burning questions you may have. Unfortunately, Jae will not be in attendance for this particular session.

[STAT+ Exclusive Story]

Unlock this article — plus gain access to in-depth analysis, exclusive newsletters, premium events, and real-time news alerts. Subscribe to STAT+ to stay ahead of the curve and elevate your understanding of the latest developments in the field of cancer research.

[Restricted Content Breaker Image] [Restricted Content Breaker Description] [Subscription Plan Options]

View All Plans

[Restricted Message Breaker]

To read the remainder of this captivating story, subscribe to STAT+ and immerse yourself in a world of unparalleled insight and expert analysis.

Incorporating the essence of Angus Chen’s original content, this rewritten article seamlessly integrates into a WordPress platform, providing readers with a fresh perspective on the latest updates from the AACR annual meeting. Stay informed, stay engaged, and stay ahead with STAT+.

Related Articles

Back to top button